Quick News Bit

‘The Art of Deliberate Listening’; Access Tied to Outcomes; No ‘A’ in Cancer

0

Lessons learned from the absence of sound and “the art of deliberate listening.” (Journal of Clinical Oncology)

A study from France showed that new diagnoses of metastatic colorectal cancer during the initial surge of the COVID-19 pandemic were associated with heavier tumor burden compared with prepandemic diagnoses, suggesting delayed diagnosis. (JAMA Network Open).

An HHS proposal to eliminate $300 million in funding for radiation oncology services “will be devastating to our patients and our radiation oncology teams,” leadership of the American Society for Radiation Oncology stated in comment letters sent to CMS.

When Black men have equal access to healthcare services, their prostate cancer outcomes are similar to those of white men. (Giddy)

Final results from a phase III randomized trial in HER2-positive metastatic breast cancer showed no improvement in overall survival with margetuximab (Margenza) versus trastuzumab (Herceptin), MacroGenics announced.

Cancer is not “a” disease but rather a conglomeration of more than 200 diseases that all have one thing in common. (American Association for Cancer Research)

Sen. Amy Klobuchar (D-Minn.) said she was successfully treated for breast cancer earlier this year, after routine mammography detected calcifications. (CNN)

Vaccination against human papillomavirus infection can prevent oropharyngeal cancer but the benefits might not appear for 25 years. (JAMA Oncology)

Many patients with cancer continue to receive drugs that received accelerated approval but ultimately did not pan out in confirmatory studies. (The BMJ)

A community’s ability to eliminate cervical cancer may depend more on affluence than science. (American Association for Cancer Research)

Results of a preliminary clinical trial showed that 42% of patients with KRAS-mutated metastatic colorectal cancer responded to the PLK1 inhibitor onvansertib plus chemotherapy, Cardiff Oncology announced.

Annual new diagnoses of neuroendocrine tumors will increase by 25,000 over the next decade in eight major economic markets of the world. (GlobalData)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined <em>MedPage Today</em> in 2007. Follow

For all the latest Health News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment